Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
US-9388208-B2 · Jul 12, 2016 · US
US10988498B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10988498-B2 |
| Application number | US-201816011055-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 18, 2018 |
| Priority date | Sep 21, 2009 |
| Publication date | Apr 27, 2021 |
| Grant date | Apr 27, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are processes and intermediates for the syntheses of nucleosides of pyrrolo[1,2-f][1,2,4]triazinyl and imidazo[1,2-f][1,2,4]triazinyl heterocycles of Formula I.
Opening claim text (preview).
What is claimed is: 1. A compound that is or an acceptable salt thereof.
containing five-membered rings with nitrogen as a ring hetero atom · CPC title
Processes for the preparation of sugar derivatives · CPC title
Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22 · CPC title
having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides · CPC title
Heterocyclic radicals containing only nitrogen atoms as ring hetero atom · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.